MedTrace Logo

Use of Corticosteroids in Third Molar Surgery

NCT05752305 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 84

Last updated 2023-12-06

No results posted yet for this study

Summary

Surgical extraction of retained lower third molars is associated with the development of postoperative complications, including inflammation, trismus and postoperative pain, that lead to a decrease in patients' quality of life. Therefore, the use of drugs is essential to reduce the morbidity associated with surgery, with NSAIDs and corticosteroids being the most commonly used drugs.

Conditions

Interventions

DRUG

Dexamethasone 4 Mg/mL Injectable Solution

Preoperative submucosal administration of 8mg of dexamethasone or 40mg of methylprednisolone.

DRUG

MethylPREDNISolone 40 Mg/mL Injectable Suspension

Preoperative submucosal administration of 8mg of dexamethasone or 40mg of methylprednisolone.

Sponsors & Collaborators

  • Universidad de Granada

    lead OTHER

Principal Investigators

  • Unai Fernández · Universidad de Granada

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-01-15
Primary Completion
2023-07-01
Completion
2023-07-15

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05752305 on ClinicalTrials.gov